Status:

UNKNOWN

Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women

Lead Sponsor:

Aswan University Hospital

Conditions:

IUCD Complication

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

To compare the effect of vaginal dinoprostone versus vaginal misoprostol administered before the copper intrauterine device(IUD) insertion in reducing IUD insertion pain and the difficulty in insertin...

Detailed Description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable,...

Eligibility Criteria

Inclusion

  • multi parous women requesting copper IUD insertion
  • body mass index more than 25

Exclusion

  • pregnancy,
  • null parous women,
  • contraindications or allergy to dinoprostone or misoprostol,contraindication to IUD insertion,
  • untreated active cervicitis or vaginitis,
  • undiagnosed abnormal uterine bleeding

Key Trial Info

Start Date :

September 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 30 2021

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04505917

Start Date

September 1 2020

End Date

August 30 2021

Last Update

August 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Aswan University Hospital

Aswān, Egypt, 81528